{"id":"https://openalex.org/W2189019003","doi":null,"title":"S/GSK1349572 is a Potent Next Generation HIV Integrase Inhibitor","display_name":"S/GSK1349572 is a Potent Next Generation HIV Integrase Inhibitor","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2189019003","mag":"2189019003"},"language":"en","primary_location":{"id":"mag:2189019003","doi":null,"is_oa":false,"landing_page_url":"http://www.hivandhepatitis.com/2009icr/ias/posters/gsk_Sato.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041689745","display_name":"Akihiko Sato","orcid":"https://orcid.org/0000-0001-6625-1679","observed_orcids":["https://orcid.org/0000-0001-6625-1679","https://orcid.org/0009-0008-0753-4394"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akihiko Sato","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6625-1679","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043194092","display_name":"Masanori Kobayashi","orcid":"https://orcid.org/0000-0003-4045-3103","observed_orcids":["https://orcid.org/0000-0003-4045-3103"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masanori Kobayashi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4045-3103","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069012570","display_name":"Tomokazu Yoshinaga","orcid":"https://orcid.org/0000-0001-5578-2212","observed_orcids":["https://orcid.org/0000-0001-5578-2212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomokazu Yoshinaga","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5578-2212","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083853","display_name":"Tamio Fujiwara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tamio Fujiwara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056086220","display_name":"Mark Underwood","orcid":"https://orcid.org/0000-0002-6803-2346","observed_orcids":["https://orcid.org/0000-0002-6803-2346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Underwood","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6803-2346","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048833977","display_name":"Brian A. Johns","orcid":"https://orcid.org/0000-0001-5526-3682","observed_orcids":["https://orcid.org/0000-0001-5526-3682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian A. Johns","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5526-3682","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015151871","display_name":"Scott A. Foster","orcid":"https://orcid.org/0000-0002-2773-7999","observed_orcids":["https://orcid.org/0000-0002-2773-7999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott A. Foster","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2773-7999","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056112208","display_name":"Richard J. Hazen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Hazen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086074491","display_name":"Robert Louis Ferris","orcid":"https://orcid.org/0000-0001-6605-2071","observed_orcids":["https://orcid.org/0000-0001-6605-2071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Ferris","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6605-2071","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Kevin Brown","orcid":"https://orcid.org/0000-0002-3238-3750","observed_orcids":["https://orcid.org/0000-0002-3238-3750"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Brown","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3238-3750","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110166075","display_name":"Edward P. Garvey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward P. Garvey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.7463,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.896062,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-integrase-inhibitors","display_name":"HIV integrase inhibitors","score":0.8450000286102295},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.7979999780654907},{"id":"https://openalex.org/keywords/hiv-2","display_name":"HIV-2","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antiviral-potency","display_name":"antiviral potency","score":0.8330000042915344},{"id":"https://openalex.org/keywords/viral-dna-integration","display_name":"viral DNA integration","score":0.9240000247955322},{"id":"https://openalex.org/keywords/integrase-resistance-mutations","display_name":"integrase resistance mutations","score":0.6679999828338623},{"id":"https://openalex.org/keywords/raltegravir-resistance","display_name":"raltegravir resistance","score":0.8180000185966492},{"id":"https://openalex.org/keywords/2-ltr-circles","display_name":"2-LTR circles","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.9206727743148804},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.7536795139312744},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.7010093331336975},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.6102811098098755},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.592317521572113},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.585386335849762},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5367245674133301},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.46888113021850586},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46151989698410034},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.44295910000801086},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.42738622426986694},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4270973205566406},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4232478141784668},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.19851750135421753},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18977683782577515},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.1703082025051117},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13816159963607788},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1047738790512085},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.061570972204208374}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2189019003","doi":null,"is_oa":false,"landing_page_url":"http://www.hivandhepatitis.com/2009icr/ias/posters/gsk_Sato.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2152880150","https://openalex.org/W7099214531","https://openalex.org/W2323335612","https://openalex.org/W2549369549","https://openalex.org/W1872178585","https://openalex.org/W1989276338","https://openalex.org/W40221034","https://openalex.org/W2153935691","https://openalex.org/W2186629758","https://openalex.org/W2590413348"],"abstract_inverted_index":{"Background:":[0],"S/GSK1349572":[1,32,85,134,172,214,256,272,296],"was":[2,33,46,76,123,166,186,257],"selected":[3],"as":[4,279],"lead":[5],"molecule":[6],"from":[7,160],"a":[8,79,140,178,258,274],"series":[9],"of":[10,23,31,44,129,144,191,261],"two-metal":[11],"binding":[12,55],"integrase":[13,51,72,88,211,263],"inhibitor":[14,73,260],"scaffolds.":[15],"We":[16],"report":[17],"here":[18],"its":[19],"antiviral":[20,100,113],"potency,":[21],"mechanism":[22],"action,":[24],"and":[25,54,62,102,107,150,152,232,238,244,247,252,266,289],"resistance":[26,63,277,294],"profile.":[27],"Methods:":[28],"Antiviral":[29],"activity":[30,220],"measured":[34],"against":[35,71,139,153,158,221],"different":[36,276],"HIV":[37,87,262,269],"strains":[38],"in":[39,49,69,89,91,126,132,181,188,219,264,267,297],"various":[40],"cell":[41,81],"lines.":[42],"Mechanism":[43],"action":[45],"determined":[47,77],"using":[48],"vitro":[50,92,265],"strand":[52,93],"transfer":[53,94],"assays,":[56,114,171],"effects":[57],"on":[58],"viral":[59,174],"DNA":[60,175],"integration,":[61],"passage":[64],"experiments.":[65],"Fold":[66],"change":[67,218],"(FC)":[68],"susceptibility":[70],"(INI)-resistant":[74],"mutants":[75,195],"with":[78,177],"HeLa-CD4":[80],"line":[82],"assay.":[83,95],"Results:":[84],"inhibited":[86],"an":[90],"In":[96,111,169],"PBMC":[97],"cells,":[98],"the":[99,115,189,210,290],"EC50":[101,157],"EC90":[103],"values":[104],"were":[105,196,207],"0.51":[106],"2.0":[108],"nM,":[109],"respectively.":[110],"MT-4":[112],"potency":[116,138],"shift":[117],"extrapolated":[118],"to":[119,284,295],"100%":[120],"human":[121],"serum":[122],"75-fold,":[124],"resulting":[125],"estimated":[127],"PA-EC90":[128],"152":[130],"nM":[131,137],"PBMCs.":[133],"had":[135,273],"low":[136,203,216,291],"broad":[141],"clade":[142],"panel":[143],"HIV-1":[145,159],"isolates":[146,165],"representing":[147],"Groups":[148],"M":[149],"O,":[151],"HIV-2.":[154],"The":[155],"mean":[156],"thirteen":[161],"subtype":[162],"B":[163],"clinical":[164],"0.52":[167],"nM.":[168],"cellular":[170,268],"blocked":[173],"integration":[176],"concomitant":[179],"increase":[180],"2-LTR":[182],"circles.":[183],"When":[184],"virus":[185],"passaged":[187],"presence":[190],"S/GSK1349572,":[192],"highly":[193],"resistant":[194,223,286],"not":[197],"isolated,":[198],"but":[199],"mutations":[200],"which":[201],"conferred":[202],"FC":[204],"(maximum":[205],"FC=4.1)":[206],"identified":[208],"within":[209],"active":[212],"site.":[213],"demonstrated":[215],"fold":[217],"raltegravir":[222,285],"site":[224],"directed":[225],"molecular":[226,287],"clones,":[227],"including":[228],"Y143R":[229],"(S/GSK1349572":[230,236,242,250],"FC=1.4":[231],"RAL":[233,239,245,253],"FC=16),":[234],"Q148K":[235],"FC=1.1":[237],"FC=83),":[240],"N155H":[241],"FC=1.2":[243],"FC=11),":[246],"G140S,":[248],"Q148H":[249],"FC=2.6":[251],"FC=>130).":[254],"Conclusions:":[255],"potent":[259],"replication":[270],"assays.":[271],"markedly":[275],"profile":[278],"evidenced":[280],"by":[281],"limited":[282],"cross-resistance":[283],"clones":[288],"level":[292],"maximum":[293],"serial":[298],"passage.":[299],"1":[300],"10":[301]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}